Diurnal Group plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Martin Whitaker, was filed 29 Nov 2017.
Diurnal Group plc: what insiders have been doing
This page follows insider dealings at Diurnal Group plc as filed with RNS (LSE). The past year has been quiet: not a single insider filing for Diurnal Group plc. The previous disclosure was published on 5 August 2019.
Since 2016, the database holds 3 purchases and 2 sales by insiders of the company.
This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
- 143,443 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20190805122707_14176603_20200326185059081_37348-0
- 86,066 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20190805122707_14176603_20200326185059081_37348-1
- 30,256 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20190805122707_14176603_20200326185059081_37348-2
- 255,105 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20181204130848_13891086_20200330111407906_2777-0
- 204,083 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20181204130848_13891086_20200330111407906_2777-1
- 71,743 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20181204130848_13891086_20200330111407906_2777-2
- 35,580 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20180710133656_13712493_20200330111420698_18605-0
- 22,682 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20180710133656_13712493_20200330111420698_18605-1
- 9,381 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20180710133656_13712493_20200330111420698_18605-2
- 10,000 shares@ £2.02100.0% of flowXLONISIN GB00BDB6Q760FCA-NSM:LSE20180405140810_13593643_20200330111354662_22067-0
- 5,500 shares@ £1.99100.0% of flowXLONISIN GB00BDB6Q760FCA-NSM:LSE20180405140810_13593643_20200330111354662_22067-2
- 1,481 shares@ £1.35100.0% of flowXLONISIN GB00BDB6Q760FCA-NSM:LSE20171129122019_13447959_20200330131535045_23865-2Canonical exit: 25 Feb 2018 (T+90)
- 3,703 shares@ £1.35100.0% of flowXLONISIN GB00BDB6Q760FCA-NSM:LSE20171129122019_13447959_20200330131535045_23865-0Canonical exit: 25 Feb 2018 (T+90)
- 2,222 shares@ £1.35100.0% of flowXLONISIN GB00BDB6Q760FCA-NSM:LSE20171129122019_13447959_20200330131535045_23865-1Canonical exit: 25 Feb 2018 (T+90)
- 148,698 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20171108120001_13424844_20200330131534264_6895-0
- 94,795 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20171108120001_13424844_20200330131534264_6895-1
- 404,762 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20170508100355_13217497_20200330131530749_5747
- 202,898 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20161109093657_013029271_20200330143612215_7519-0
- 103,858 sharesOutside a trading venueISIN GB00BDB6Q760FCA-NSM:LSE20161109093657_013029271_20200330143612215_7519-1
19 of 19 declarations
About Diurnal Group plc
Diurnal Group plc is a biopharmaceutical company focused on developing treatments for hormonal disorders. It is listed on the London Stock Exchange under the ticker XLON.
